Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection
- PMID: 37211218
- PMCID: PMC10197432
- DOI: 10.1016/j.jinf.2023.05.014
Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Comment on
-
Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.J Infect. 2022 May;84(5):e45-e47. doi: 10.1016/j.jinf.2022.03.006. Epub 2022 Mar 9. J Infect. 2022. PMID: 35278482 Free PMC article. No abstract available.
-
Cellular immunity against SARS-CoV-2 depends on the serological status.J Infect. 2023 Jul;87(1):57-58. doi: 10.1016/j.jinf.2023.04.003. Epub 2023 Apr 14. J Infect. 2023. PMID: 37060925 Free PMC article. No abstract available.
References
-
- Wherry E.J., Barouch D.H. T cell immunity to COVID-19 vaccines. Science. 2022;377(6608):821–822. PubMed PMID: 35981045. Epub 20220818. - PubMed
-
- Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23(2):186–193. PubMed PMID: 35105982. Epub 2022/02/03. - PubMed
-
- Ledford H. 'Killer' immune cells still recognize Omicron variant. Nature. 2022;601(7893):307. PubMed PMID: 35017690. Epub 2022/01/13. - PubMed
-
- Lippi G., Mattiuzzi C., Henry B.M. Is cellular immunity the future key for deciphering and monitoring COVID-19 vaccines efficacy? J Lab Precis Med. 2022;7
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
